Skip to main content
Decision

UK REACH authorisation for Abbott Laboratories Limited (review report), 5 August 2026

Decision on an application for authorisation (review report) under UK REACH.

Documents

UK REACH authorisation for Abbott Laboratories Limited (Review Report), 5 August 2026

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email defra.helpline@defra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Decision on an application for authorisation under UK REACH.

Substance name

4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated.

Authorised use

Professional use of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated as a surfactant in the final use of In-Vitro Diagnostic Devices for clinical testing using ARCHITECT and Alinity automated analyser systems.

Holder of the authorisation and authorisation number

Abbott Laboratories Limited (UKREACH/26/09/00)

Date of decision

5 August 2026

Updates to this page

Published 7 September 2026

Sign up for emails or print this page